Rheumatology and Orthopedics Flashcards
RA step up tx
MTX for 6 months
- persistent sx - add sulfalazine/plaquenil or step up
- step up = add biologic - TNF inhibitor
before start TNF inhibitor - check?
TB, hep C, hep B
target uric acid when treating gout
less than 6
4SKIN RASH NIANA
Lupus manifestations:
- 4 rashes - malar, discoid, photosensitive, oral ulcers
- RASH - renal, arthritis, serositis, hematologic
- NIANA - neurologic, immunologic, ANA
rash that spares nasolabial folds
malar rash
diagnosis of fibro requires
symptoms more than 3 months
normal inflammatory markers
tx giant cell arteritis
high dose pred
tx PMR
low dose pred
pseudogout crystals?
calcium pyrophosphate
DIP arthritis and arthritis mutilans
psoriatic arthritis
- also - pencil in cup deformity
prognostic factors for erosive RA
anti-CCP and RF early development affecting multi joints radiographic erosions lower SES and education elevated ESR and CRP functional limitations
arthritis at base of thumb
OA
5% risk of developing this in sjogrens - commonly in parotid gland
non-hodgkin lymphoma
risk fx for developing lymphoma in sjogrens
anti Ro/SSA and La/SSB Abs RF Ab cryo hypocomplement lymphopenia
negative ANCA and concern for GPA?
does NOT rule it out
pain and paresthesias sole of foot, distal foot, toes
tarsal tunnel syndrome
locking of knee with extension
meniscal tear
ottawa ankle rules
X-ray ankle if:
- pain at malleolar zone
- tender tip medial malleolus
- tender tip of lateral malleolus
- unable to bear weight
X-ray foot if:
- pain midfoot zone
- tender at navicular
- tender base 5th metatarsal
- unable bear weight
synovial fluid in septic arthritis
WBC typically 50-150k
gram stain - negative in 20-30% of cases
primary raynauds work up
normal nailfold capillaroscopy
normal ANA and ESR
tx - CCBs
erythema infectiousum
fifth disease - parvo b19
parvo b19 in sickle cell
aplastic crisis
diagnosis parvo b19
acute - B19 IgM in immunocompetent or NAAT for DNA in immunocompromised
prior - B19 IgG
reactivation - NAAT for DNA
progressive osteoporosis management
first = oral bispho
if BMD loss less 5% continue and DXA 2 years
if BMD loss more 5% - consider IV bispho, teriparatide, denosumab
severe osteoporosis T score
less than -3.5
screen if progressive osteoporisis
hyperT, hyperPTH, MM, malabsorption, liver disease, CKD
triad of feltys
neutropenia, RA, splenomegaly
in 1% of patients with seropositive advanced RA
extra-articular manifestations of feltys
mononeuritis multiplex, necrotizing skin lesions, pleuropericarditis, LAD, episcleritis
sweets syndrome
neutrophilic dermatosis associated with malignancy and autoimmune disease
- erythematous plaques with pseudo blistering and pustules - face, necks, chest, extremities
tx of PMR
15-20mg / d prednisone
tx of reactive arthritis
NSAIDS (abx don’t work)
associations with marfans
AO root dilation and dissection
ectopia lentis
mitral valve prolapse
PTX
PAN association
hep B
vessels involved in PAN
typically - mesenteric and renal vessels (spares pulmonary)
tx PAN
pred and cyclophosphamide
ACEI for HTN
essential mixed cryo association
hep C
- will see low complement